SCHEMBL7873563

SCHEMBL7873563

N=C(N)N(Cc1ccccc1)C(=O)c1cc2ccccc2[nH]1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.56
IDO1 P14902 1/20 0.53
KDM4E B2RXH2 2/20 0.50
MAPT P10636 1/20 0.50
DAO P14920 1/20 0.50
HPGD P15428 1/20 0.50
SRD5A2 P31213 1/20 0.50
HSD17B10 Q99714 1/20 0.50
ATM Q13315 1/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
MAPK1 P28482 1/20 0.49
ACKR3 P25106 1/20 0.48
RXFP1 Q9HBX9 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
FLT3 P36888 1/20 0.48
HDAC1 Q13547 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7877804 0.99 AR (0.55) ARIDO1KDM4EMAPTDAO
SCHEMBL8627247 0.91 AR (0.47) ARIDO1KDM4EMAPTDAO
Hydrochloric Acid SCHEMBL7882303 0.90 AR (0.47) ARIDO1KDM4EMAPTDAO
Hydrochloric Acid SCHEMBL7882110 0.89 AR (0.46) ARIDO1KDM4EMAPTDAO
Hydrochloric Acid SCHEMBL7881242 0.88 KDM4E (0.45) ARIDO1KDM4EMAPTDAO
Hydrochloric Acid SCHEMBL7879984 0.86 AR (0.50) ARIDO1KDM4EMAPTDAO
Hydrochloric Acid SCHEMBL7880907 0.86 MEN1 (0.54) KDM4EMAPTHSD17B10ALDH1A1RXFP1
SCHEMBL7873301 0.86 PDGFRB (0.45) ARIDO1KDM4EMAPTDAO
Hydrochloric Acid SCHEMBL7873549 0.85 PDGFRB (0.45) ARIDO1KDM4EMAPTDAO
Hydrochloric Acid SCHEMBL7873820 0.84 AR (0.51) ARIDO1KDM4EMAPTDAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed